Arsenicum album 200C in preventing COVID 19 respiratory illness and ILI
Phase 3
- Registration Number
- CTRI/2021/08/035905
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Healthy individuals living in the same community
2. Written Informed consent by head of the family
3. No symptom of Influenza like illness/COVID-19 at the time of enrolment.
Exclusion Criteria
1. Individuals with symptoms of Influenza like illness/ COVID-19 in last 14 days
2. Pregnant women and lactating mother
3. Child below age of 1 year.
4. Individuals taking other homoeopathic medicines for prevention of Influenza like
illness/COVID-19
5. Patients with malignancy, immunocompromised state, life threatening diseases, end stage
diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of Influenza-like illness & COVID-19 type respiratory illness.Timepoint: Weekly till completion of 1 year
- Secondary Outcome Measures
Name Time Method 1. Changes/severity of symptoms between the groups. <br/ ><br>2. Prevalence of other acute diseases. <br/ ><br>3. Time to recovery. <br/ ><br>4. Need of hospitalization.Timepoint: Weekly till completion of 1 year